Latest News

  • 27 May 2016

    TapImmune to Present at SeeThruEquity and Marcum Conferences...

    TapImmune,Inc. (TPIV), a clinical-stage immuno-oncology company specializing in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer & metastatic disease, today announced it will be presenting at two financial conferences in New York...

    more >

  • 28 Apr 2016

    TapImmune to Present at the 3rd Annual Growth Capital Expo i...

    JACKSONVILLE, FL, April 28, 2016 / TapImmune,Inc. (TPIV), a clinical-stage immune-oncology company specializing in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer & metastatic disease, today announced it will be presenting at the...

    more >